Fig. 2.
Effect of activation peptide mutations on autoactivation of human cationic trypsinogen. Approximately 2 μM wild-type or mutant trypsinogen (final concentration in a final volume of 100 μl) was incubated at 37°C, in 0.1 M Tris-HCl (pH 8.0) with no Ca2+ added (A) or with 1 mM CaCl2 (B) or in 0.1 M Na-acetate buffer (pH 5.0) in the presence of 2 mg/ml bovine serum albumin (C). Aliquots of 2.5 μl were withdrawn from reaction mixtures at indicated times and trypsin activity was determined with the synthetic substrate N-CBZ-Gly-Pro-Arg-p-nitroanilide. Activity was expressed as percentage of the potential total activity, as determined on similar zymogen samples activated with enteropeptidase

Effect of activation peptide mutations on autoactivation of human cationic trypsinogen. Approximately 2 μM wild-type or mutant trypsinogen (final concentration in a final volume of 100 μl) was incubated at 37°C, in 0.1 M Tris-HCl (pH 8.0) with no Ca2+ added (A) or with 1 mM CaCl2 (B) or in 0.1 M Na-acetate buffer (pH 5.0) in the presence of 2 mg/ml bovine serum albumin (C). Aliquots of 2.5 μl were withdrawn from reaction mixtures at indicated times and trypsin activity was determined with the synthetic substrate N-CBZ-Gly-Pro-Arg-p-nitroanilide. Activity was expressed as percentage of the potential total activity, as determined on similar zymogen samples activated with enteropeptidase

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close